Grantham, Mayo, Van Otterloo & Co (GMO)’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.56M Sell
37,757
-30,567
-45% -$3.34M 0.01% 342
2026
Q1
$5.67M Sell
68,324
-6,989
-9% -$599K 0.01% 312
2025
Q4
$6.44M Buy
75,313
+2,221
+3% +$186K 0.02% 275
2025
Q3
$6.11M Buy
73,092
+508
+0.7% +$46.4K 0.02% 272
2025
Q2
$7.35M Sell
72,584
-2,285
-3% -$233K 0.02% 254
2025
Q1
$7.95M Buy
74,869
+8,366
+13% +$867K 0.03% 264
2024
Q4
$7.28M Buy
66,503
+3,155
+5% +$367K 0.02% 279
2024
Q3
$9.17M Sell
63,348
-505
-0.8% -$68.9K 0.03% 278
2024
Q2
$9.32M Buy
63,853
+20,637
+48% +$2.89M 0.03% 272
2024
Q1
$6.21M Buy
43,216
+39,510
+1,066% +$4.5M 0.02% 292
2023
Q4
$346K Buy
+3,706
New +$342K ﹤0.01% 433
2020
Q2
Sell
-93,500
Closed -$1.59M 767
2020
Q1
$1.59M Buy
+93,500
New +$2.98M 0.01% 426

Other funds holding CROX

Grantham, Mayo, Van Otterloo & Co (GMO)'s CROX Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Crocs (CROX) stake by 45% in Q2 2026, selling an estimated $3.34M and leaving 37,757 shares worth $4.56M. The position accounts for 0.01% of the portfolio, ranked #342.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CROX in Q1 2020 and has held it in 12 quarters since. The position peaked at $9.32M in Q2 2024. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 37,757 shares of Crocs worth $4.56M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 30,567 Crocs shares in Q2 2026, an estimated $3.34M.
  • Crocs made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #342 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Crocs in Q1 2020 and has held it in 12 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Crocs position peaked at $9.32M in Q2 2024.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.